Summit for Stem Cell Foundation’s scientists are developing a treatment protocol that calls for the reprogramming of autologous [the patient’s own] stem cells to produce dopamine to treat PD. An important aspect of Parkinson’s disease is neural degeneration, which vastly decreases the production of dopamine, a hormone necessary for proper movement. By differentiating stem cells to replace the damaged neurons, the treatment holds the promise of significantly alleviating the symptoms [loss of muscle control] associated with Parkinson’s.
In animal models, mice who have had their dopamine-producing neurons compromised were implanted with stem cells that were differentiated into neurons that produce dopamine. According to Bratt-Leal, a leading researcher, “Implanting new neurons has shown tremendous promise in animal models” and should lead to clinical trials in the not too distant future.
As treatments emerge, we believe the best stem cells to use will be the patient’s own [autologous stem cells] as this negates the need to find a suitable donor and eliminates the chances of rejection of the transplanted tissue. To learn how to bank your own valuable stem cells to insure your future health, visit www.StemSave.com or call 877-783-6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.